Antiaggregation in Primary Prevention of Vascular Access for Hemodialysis

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2013
This is a prospective study consisting in testing whether systematic use of aspirin is beneficial for primary prevention of vascular access for hemodialysis attested by doppler ultrasound exam. The investigators will study aspirin resistance in the population of patients undergoing hemodialysis. The investigators will test sensibility of resistant patients to aspirin dose escalation. PFA-100 is the biologic test used in this study to define aspirin resistance.
Epistemonikos ID: 16f7e3c7265ad47558b57f9936a0ebceea7b37e3
First added on: May 11, 2024